when were glp-1 agonists approved for weight loss Indications GLP-1/GIP RA Summary Sheet and Beyond! Navigating the -tides: Medication-Assisted Weight

While medications may share GLP-1 receptor activity, FDA approval applies to specific products and patient populations studied in clinical trials

PubMed, Pham, Hung, et al

HFpEF, HFmrEF or HFrEF, respectively), we focus the review on HFpEF and HFrEF

One study demonstrated that GLP-1 can activate LTP in the brain and ameliorate cognitive dysfunction in a neurodegenerative disorder model (McClean et al., 2011)

So I think there's a lot of heterogeneity or variety in patients

On the other hand, several case reports have linked the use of these drugs, mainly exenatide, with the occurrence of acute kidney injury, primarily through hemodynamic derangement due to nausea, vomiting, and diarrhea